mTOR Modulates CD8+ T Cell Differentiation in Mice with Invasive Pulmonary Aspergillosis

Hao Wang1, Yu Xiao2, Longxiang Su1

  • 1Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.

Open Life Sciences
|April 5, 2021
PubMed

Insights

The mechanistic target of rapamycin (mTOR) pathway drives CD8+ T effector memory (Tem) cell proliferation and differentiation in invasive pulmonary aspergillosis (IPA). This pathway regulates T-bet and Eomesodermin expression, enhancing antifungal immune responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Microbiology

Background:

  • CD8+ T cells are crucial for fighting intracellular pathogens.
  • mTOR pathway activity influences CD8+ T effector memory (Tem) cell differentiation during fungal infections.

Purpose of the Study:

  • To investigate the molecular mechanisms of CD8+ Tem cell proliferation and differentiation via the mTOR pathway in immunosuppressed mice with invasive pulmonary aspergillosis (IPA).

Main Methods:

  • Established an immunosuppressed IPA mouse model.
  • Administered rapamycin or interleukin-12 (IL-12) to mice.
  • Analyzed lung tissues and blood samples for immune cell markers and gene expression.

Main Results:

  • IL-12 treatment increased mTOR, S6 kinase, CD8+ Tem cells, and interferon-γ expression.
  • Rapamycin treatment decreased these markers.
  • IL-12 induced T-bet and inhibited Eomesodermin; rapamycin showed opposite effects.

Conclusions:

  • The mTOR pathway promotes CD8+ T cell proliferation and differentiation by modulating T-bet and Eomesodermin.
  • This regulation is key to immune responses against fungal infections in IPA.

Related Concept Videos